Article Versions Notes

Gammeltoft KA, Zhou Y, Ryberg LA, Pham LV, Binderup A, Hernandez CRD, Offersgaard A, Fahnøe U, Peters GHJ, Ramirez S, et al. Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir. Viruses. 2023; 15(9):1970. https://doi.org/10.3390/v15091970

Gammeltoft, Karen Anbro, Yuyong Zhou, Line Abildgaard Ryberg, Long V. Pham, Alekxander Binderup, Carlos Rene Duarte Hernandez, Anna Offersgaard, Ulrik Fahnøe, Günther Herbert Johannes Peters, Santseharay Ramirez, and et al. 2023. "Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir" Viruses 15, no. 9: 1970. https://doi.org/10.3390/v15091970

Gammeltoft, K. A., Zhou, Y., Ryberg, L. A., Pham, L. V., Binderup, A., Hernandez, C. R. D., Offersgaard, A., Fahnøe, U., Peters, G. H. J., Ramirez, S., Bukh, J., & Gottwein, J. M. (2023). Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir. Viruses, 15(9), 1970. https://doi.org/10.3390/v15091970